IMRX Immuneering Corp
Healthcare · Pharmaceutical Preparations · Market cap: $240.1M
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $122.5K | $0 |
| 2022-Q2 | $54.3K | $0 |
| 2022-Q3 | $0 | $0 |
| 2022-Q4 | $0 | $0 |
| 2023-Q1 | $0 | $0 |
| 2023-Q2 | $0 | $0 |
| 2023-Q3 | $0 | $0 |
| 2023-Q4 | $0 | $0 |
| 2024-Q1 | $478.2K | $2.8M |
| 2024-Q2 | $0 | $1.2M |
| 2024-Q3 | $0 | $0 |
| 2024-Q4 | $0 | $0 |
| 2025-Q1 | $0 | $0 |
| 2025-Q2 | $277.1K | $0 |
| 2025-Q3 | $145.8K | $0 |
| 2025-Q4 | $64.0K | $0 |
| 2026-Q1 | $234.5K | $0 |
| 2026-Q2 | $36.0K | $0 |
| 2026-Q3 | $0 | $0 |
| 2026-Q4 | $0 | $0 |
Bought$1.4M44 buy days
Sold$3.9M3 sell days
Net insider flow-$2.5Mnet selling · 5 years
Latest trade2026-06-23Zeskind Benjamin J.
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-06-23 | Buy | Zeskind Benjamin J. | CEO | 2,400 | $4.56 | $10.9K | 1 |
| 2026-06-15 | Buy | Hall Brett Matthew | Other C-suite | 6,035 | $4.15 | $25.0K | 1 |
| 2026-01-16 | Buy | Brakewood Harold Eugene | Other C-suite | 5,250 | $4.76 | $25.0K | 1 |
| 2026-01-15 | Buy | Schall Thomas J. | Director | 21,645 | $4.67 | $101.1K | 1 |
| 2026-01-15 | Buy | Hall Brett Matthew | Other C-suite | 2,298 | $4.57 | $10.5K | 1 |
| 2026-01-13 | Buy | Neufeld Leah R | Other C-suite | 2,626 | $4.15 | $10.9K | 1 |
| 2026-01-12 | Buy | Feinberg Peter | Director | 20,000 | $4.35 | $87.0K | 1 |
| 2025-10-03 | Buy | Feinberg Peter | Director | 7,500 | $6.67 | $50.0K | 1 |
| 2025-10-01 | Buy | Bookman Michael | Other C-suite | 1,020 | $6.83 | $7.0K | 1 |
| 2025-10-01 | Buy | Neufeld Leah R | Other C-suite | 800 | $6.38 | $5.1K | 1 |
| 2025-10-01 | Buy | Morales Mallory | Other C-suite | 300 | $6.39 | $1.9K | 1 |
| 2025-09-30 | Buy | Feinberg Peter | Director | 7,500 | $7.03 | $52.7K | 1 |
| 2025-09-29 | Buy | Feinberg Peter | Director | 5,000 | $7.18 | $35.9K | 1 |
| 2025-07-02 | Buy | Zeskind Benjamin J. | CEO | 7,015 | $3.53 | $24.8K | 1 |
| 2025-07-02 | Buy | HAUSMAN DIANA | Director | 5,500 | $3.61 | $19.9K | 2 |
| 2025-07-02 | Buy | Neufeld Leah R | Other C-suite | 700 | $3.57 | $2.5K | 1 |
| 2025-07-01 | Buy | Zeskind Benjamin J. | CEO | 2,985 | $3.38 | $10.1K | 1 |
| 2025-06-27 | Buy | Schall Thomas J. | Director | 9,500 | $3.66 | $34.8K | 1 |
| 2025-06-23 | Buy | Hall Brett Matthew | Other C-suite | 6,007 | $2.43 | $14.6K | 1 |
| 2025-06-20 | Buy | Hall Brett Matthew | Other C-suite | 7,415 | $2.70 | $20.0K | 1 |
| 2025-06-20 | Buy | Brakewood Harold Eugene | Other C-suite | 1,900 | $2.53 | $4.8K | 1 |
| 2025-06-18 | Buy | Feinberg Peter | Director | 25,000 | $2.53 | $63.2K | 1 |
| 2025-06-18 | Buy | Zeskind Benjamin J. | CEO | 21,000 | $2.39 | $50.2K | 1 |
| 2025-06-17 | Buy | Schall Thomas J. | Director | 40,485 | $2.21 | $89.5K | 1 |
| 2024-04-01 | Sell | Cormorant Asset Management, LP | 10% owner | 400,000 | $2.90 | $1.2M | 8 |
| 2024-03-22 | Buy | Feinberg Peter | Director | 25,000 | $2.55 | $63.7K | 1 |
| 2024-03-22 | Buy | Brakewood Harold Eugene | Other C-suite | 3,900 | $2.57 | $10.0K | 1 |
| 2024-03-22 | Buy | Schall Thomas J. | Director | 2,900 | $2.55 | $7.4K | 1 |
| 2024-03-22 | Buy | Morales Mallory | Other C-suite | 393 | $2.55 | $1.0K | 1 |
| 2024-03-21 | Buy | Morales Mallory | Other C-suite | 1,107 | $2.72 | $3.0K | 1 |
| 2024-03-20 | Buy | Hall Brett Matthew | Other C-suite | 7,000 | $2.86 | $20.0K | 1 |
| 2024-03-20 | Buy | Neufeld Leah R | Other C-suite | 3,818 | $2.88 | $11.0K | 1 |
| 2024-03-19 | Buy | Feinberg Peter | Director | 25,000 | $2.56 | $64.0K | 1 |
| 2024-03-19 | Buy | Zeskind Benjamin J. | CEO | 20,000 | $2.77 | $55.4K | 1 |
| 2024-03-18 | Buy | BERMAN ANN E | Director | 57,965 | $2.13 | $123.5K | 1 |
| 2024-03-18 | Buy | Feinberg Peter | Director | 50,000 | $2.38 | $119.2K | 2 |
| 2024-03-15 | Sell | Cormorant Asset Management, LP | 10% owner | 400,000 | $2.14 | $856.0K | 1 |
| 2024-03-14 | Sell | Cormorant Asset Management, LP | 10% owner | 509,091 | $3.72 | $1.9M | 4 |
| 2022-05-25 | Buy | Hall Brett Matthew | Other C-suite | 2,551 | $3.92 | $10.0K | 1 |
| 2022-05-17 | Buy | Bookman Michael | General counsel | 1,000 | $4.88 | $4.9K | 1 |
| 2022-05-16 | Buy | KEATING LAURIE | Director | 7,000 | $5.00 | $35.0K | 1 |
| 2022-05-12 | Buy | Amin Biren | CFO | 1,000 | $4.42 | $4.4K | 1 |
| 2022-03-23 | Buy | Zeskind Benjamin J. | CEO | 3,000 | $8.02 | $24.1K | 1 |
| 2022-03-23 | Buy | Hall Brett Matthew | Other C-suite | 1,050 | $7.91 | $8.3K | 1 |
| 2022-03-22 | Buy | Barrett Scott | Other C-suite | 900 | $7.49 | $6.7K | 1 |
| 2022-03-15 | Buy | Feinberg Peter | Director | 6,667 | $6.75 | $45.0K | 1 |
| 2022-03-15 | Buy | BERMAN ANN E | Director | 6,000 | $6.40 | $38.4K | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Cormorant Asset Management, LP | 10% owner | $0 | $3.9M | 2024-04-01 |
| Feinberg Peter | Director | $580.8K | $0 | 2026-01-12 |
| Schall Thomas J. | Director | $232.7K | $0 | 2026-01-15 |
| Zeskind Benjamin J. | CEO | $175.4K | $0 | 2026-06-23 |
| BERMAN ANN E | Director | $161.9K | $0 | 2024-03-18 |
| Hall Brett Matthew | Other C-suite | $108.5K | $0 | 2026-06-15 |
| Brakewood Harold Eugene | Other C-suite | $39.8K | $0 | 2026-01-16 |
| KEATING LAURIE | Director | $35.0K | $0 | 2022-05-16 |
| Neufeld Leah R | Other C-suite | $29.5K | $0 | 2026-01-13 |
| HAUSMAN DIANA | Director | $19.9K | $0 | 2025-07-02 |
| Bookman Michael | Other C-suite | $11.8K | $0 | 2025-10-01 |
| Barrett Scott | Other C-suite | $6.7K | $0 | 2022-03-22 |
| Morales Mallory | Other C-suite | $5.9K | $0 | 2025-10-01 |
| Amin Biren | CFO | $4.4K | $0 | 2022-05-12 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2026-01-12 → 2026-01-16 | 5 | $234.5K | 50 | +15.3% (+16.7% raw) | +18.0% (+23.3% raw) | -13.6% (-0.7% raw) | closed |
| 2025-09-29 → 2025-10-03 | 4 | $152.6K | 37 | +2.1% (+3.5% raw) | -3.0% (-0.3% raw) | -23.1% (-18.7% raw) | closed |
| 2025-06-17 → 2025-07-02 | 7 | $334.3K | 63 | +54.0% (+62.7% raw) | +228.9% (+246.4% raw) | +103.2% (+124.2% raw) | closed |
| 2024-03-18 → 2024-03-22 | 8 | $478.2K | 66 | -31.6% (-35.5% raw) | -49.2% (-49.5% raw) | -25.0% (-13.3% raw) | closed |
| 2022-05-12 → 2022-05-25 | 4 | $54.3K | 37 | +3.0% (-0.6% raw) | +32.0% (+43.6% raw) | +39.0% (+44.2% raw) | closed |
| 2022-03-15 → 2022-03-23 | 5 | $122.5K | 57 | -21.4% (-27.7% raw) | -19.9% (-37.2% raw) | +45.8% (+29.3% raw) | closed |
| 2021-08-03 | 10 | $15.9M | 61 | +33.0% (+36.1% raw) | +47.8% (+53.2% raw) | -53.1% (-48.4% raw) | closed |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.